Universal Cells
Catherine Nguyen is a Research Associate at Universal Cells, where Catherine executes gene editing of induced pluripotent stem cells. Prior to this role, Catherine worked as a Research Scientist at Marta Scatena Lab, focusing on projects related to cardiovascular inflammation. Catherine also has experience as an Undergraduate Researcher at both Marta Scatena Lab and Suzie Pun Lab Group during their time at the University of Washington, where Catherine earned a Bachelor of Science in Bioengineering and Biomedical Engineering.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.